Form D · Biotechnology

Vernal Biosciences, Inc.

Colchester, VT · CIK 0001861147

Offering snapshot reported Jun 16, 2023 · SEC filing

Reported sold
$41M
Offering amount: $41M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 10, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$20.5M$41MMay 25, 2022: $20,998,407.00May 25, 2022Jun 16, 2023: $40,998,390.00Jun 16, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$20,998,407 → $40,998,390

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 16, 2023Amendment$40,998,390$19,999,983vs May 25, 202210SEC filing
May 25, 2022Initial$20,998,407No comparison10SEC filing
May 24, 2021Initial$1,500,000No comparison9SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-446902

Source: Form D, filed Jun 16, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Errik Anderson Director
David Anderson Director
Christian Cobaugh Director, Executive
Daniella Kranjac Director
Gustavo Mahler Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
261 Mountain View Drive
Colchester, VT, 05461